1. Home
  2. BOLT vs MXC Comparison

BOLT vs MXC Comparison

Compare BOLT & MXC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BOLT
  • MXC
  • Stock Information
  • Founded
  • BOLT 2015
  • MXC 1972
  • Country
  • BOLT United States
  • MXC United States
  • Employees
  • BOLT N/A
  • MXC N/A
  • Industry
  • BOLT Biotechnology: Pharmaceutical Preparations
  • MXC Oil & Gas Production
  • Sector
  • BOLT Health Care
  • MXC Energy
  • Exchange
  • BOLT Nasdaq
  • MXC Nasdaq
  • Market Cap
  • BOLT 25.3M
  • MXC 24.0M
  • IPO Year
  • BOLT 2021
  • MXC N/A
  • Fundamental
  • Price
  • BOLT $0.57
  • MXC $12.16
  • Analyst Decision
  • BOLT Hold
  • MXC
  • Analyst Count
  • BOLT 5
  • MXC 0
  • Target Price
  • BOLT $1.25
  • MXC N/A
  • AVG Volume (30 Days)
  • BOLT 126.9K
  • MXC 9.9K
  • Earning Date
  • BOLT 11-12-2024
  • MXC 11-07-2024
  • Dividend Yield
  • BOLT N/A
  • MXC 0.82%
  • EPS Growth
  • BOLT N/A
  • MXC N/A
  • EPS
  • BOLT N/A
  • MXC 0.57
  • Revenue
  • BOLT $9,779,000.00
  • MXC $6,926,917.00
  • Revenue This Year
  • BOLT $16.30
  • MXC N/A
  • Revenue Next Year
  • BOLT N/A
  • MXC N/A
  • P/E Ratio
  • BOLT N/A
  • MXC $21.35
  • Revenue Growth
  • BOLT 35.86
  • MXC N/A
  • 52 Week Low
  • BOLT $0.55
  • MXC $9.02
  • 52 Week High
  • BOLT $1.56
  • MXC $16.52
  • Technical
  • Relative Strength Index (RSI)
  • BOLT 29.99
  • MXC 49.35
  • Support Level
  • BOLT $0.63
  • MXC $11.70
  • Resistance Level
  • BOLT $0.69
  • MXC $13.36
  • Average True Range (ATR)
  • BOLT 0.03
  • MXC 0.52
  • MACD
  • BOLT -0.01
  • MXC 0.06
  • Stochastic Oscillator
  • BOLT 3.49
  • MXC 38.06

About BOLT Bolt Biotherapeutics Inc.

Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. The company's pipeline candidates are built on our deep expertise in myeloid biology and cancer drug development. The company's proprietary Boltbody ISAC platform technology combines tumor-targeting antibodies with immune-stimulating linker-payloads. The company's pipeline consists of BDC-1001, BDC-3042, and Next-Gen ISAC.

About MXC Mexco Energy Corporation

Mexco Energy Corporation is an independent oil and gas company. It is engaged in the exploration, development, and production of natural gas and crude oil properties located in the United States. The company carried out its operation in the Permian Basin of West Texas. It is focusing on two primary areas, the Delaware Basin located in the Western portion of the Permian Basin including Lea and Eddy Counties, New Mexico and Loving County, Texas, and the Midland Basin located in the Eastern portion of the Permian Basin including Reagan, Upton, Midland, Martin, Howard, and Glasscock Counties, Texas. The company generates revenue from Oil sales, Natural gas sales, oil and gas royalty interests.

Share on Social Networks: